Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01); Correction, 53701 [2010-21795]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices
53701
TRANSACTION GRANTED EARLY TERMINATION—Continued
ET date
Trans No.
20100960
11–AUG–10 ..............................................................
20100897
13–AUG–10 ..............................................................
20100969
20100970
20100972
20100975
20100976
20100977
20100985
20100987
FOR FURTHER INFORMATION CONTACT:
Sandra M. Peay, Contact Representative
or Renee Chapman, Contact
Representative. Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room H–
303, Washington, DC 20580.
(202) 326–3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2010–21410 Filed 8–31–10; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
hsrobinson on DSK69SOYB1PROD with NOTICES
[Docket No. FDA–2010–N–0394]
Clinical Studies of Safety and
Effectiveness of Orphan Products
Research Project Grant (R01);
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
SUMMARY:
VerDate Mar<15>2010
18:24 Aug 31, 2010
Jkt 220001
ET
REQ
status
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
Party name
Nippon Telegraph and Telephone Corporation.
Dimension Data Holdings plc.
Dimension Data Holdings plc.
Nestle S.A.
LenSx Lasers, Inc.
LenSx Lasers, Inc.
KRG Capital Fund IV, LP.
Genstar Capital Partners IV, LP.
Fort Dearborn Holdings, LLC.
Nippon Telegraph and Telephone Corporation.
NextWave Wireless Inc.
PacketVideo Corporation.
Clayton, Dubilier & Rice Fund VIII, LP.
Harrington Group, Inc.
Harrington Group, Inc.
First Reserve Fund XII, LP.
Quicksilver Resources Inc.
Quicksilver Gas Services Holdings LLC.
Eaton Corporation.
Wright Line Purchaser LLC.
Wright Line Holding, Inc.
AECOM Technology Corporation.
The Veritas Capital Fund II, LP.
MT Holding Corp.
Green Equity Investors V, LP.
Ares Corporate Opportunities Fund II, LP.
AA Dental Management Holdings LLC.
General Motors Company.
AmeriCredit Corp.
AmeriCredit Corp.
Register of August 6, 2010 (75 FR
47602). The document announced the
availability of grant funds for the
support of FDA’s Office of Orphan
Products Development (OPD) grant
program. The document was published
with an error. This document corrects
that error.
FOR FURTHER INFORMATION CONTACT:
Vieda Hubbard, Acquisition Support
and Grants, Food and Drug
Administration, 5630 Fishers Lane,
Rockville, MD 20857, 301–827–7177,
email: vieda.hubbard@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In FR Doc.
2010–19354, appearing on page 47602
in the Federal Register of Friday,
August 6, 2010, the following correction
is made:
1. On page 47602, in the second
column, in the ‘‘DATES’’ section,
beginning in the sixth line, the sentence
‘‘2. The anticipated start dates are
November 2010; November 2012.’’ is
corrected to read ‘‘2. The anticipated
start dates are November 2011 and
November 2012.’’
Dated: August 26, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
[FR Doc. 2010–21795 Filed 8–31–10; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Health Center Program
Health Resources and Services
Administration, HHS.
ACTION: Notice of Non-competitive
Replacement Awards to Sunset Park
Health Council, Inc.
AGENCY:
The Health Resources and
Services Administration (HRSA) will
transfer Health Center Program (Section
330(h) of the Public Health Service Act)
funds originally awarded to Saint
Vincent’s Catholic Medical Centers of
New York to Sunset Park Health
Council, Inc., to ensure the continuity of
services to low-income, underserved,
homeless patients in New York City.
SUPPLEMENTARY INFORMATION:
Former Grantee of Record: Saint
Vincent’s Catholic Medical Centers of
New York.
Original Period of Grant Support:
November 1, 2007 to October 31, 2010.
Replacement Awardee: Sunset Park
Health Council, Inc.
Amount of Replacement Award:
$1,288,436.
SUMMARY:
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Page 53701]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21795]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0394]
Clinical Studies of Safety and Effectiveness of Orphan Products
Research Project Grant (R01); Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register of August 6, 2010 (75 FR 47602).
The document announced the availability of grant funds for the support
of FDA's Office of Orphan Products Development (OPD) grant program. The
document was published with an error. This document corrects that
error.
FOR FURTHER INFORMATION CONTACT: Vieda Hubbard, Acquisition Support and
Grants, Food and Drug Administration, 5630 Fishers Lane, Rockville, MD
20857, 301-827-7177, email: vieda.hubbard@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In FR Doc. 2010-19354, appearing on page
47602 in the Federal Register of Friday, August 6, 2010, the following
correction is made:
1. On page 47602, in the second column, in the ``DATES'' section,
beginning in the sixth line, the sentence ``2. The anticipated start
dates are November 2010; November 2012.'' is corrected to read ``2. The
anticipated start dates are November 2011 and November 2012.''
Dated: August 26, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-21795 Filed 8-31-10; 8:45 am]
BILLING CODE 4160-01-S
